ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Sequential Protocol Biopsies Post-Liver Transplant from Donors with Moderate Macrosteatosis: What Happens to the Fat?

K. Croome, D. Livingston, C. Taner, R. Nakhleh

Mayo Clinic Jacksonville, Jacksonville, FL

Meeting: 2020 American Transplant Congress

Abstract number: 375

Keywords: Donors, marginal, Graft failure, Hyperglycemia

Session Information

Session Name: Liver Retransplantation and Other Complications

Session Type: Oral Abstract Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:45pm

 Presentation Time: 4:27pm-4:39pm

Location: Virtual

*Purpose: The number of steatotic deceased donor livers encountered has continued to rise as a result of the obesity epidemic. Little is known about the histological characteristics of moderately macrosteatotic livers over time in the recipient following liver transplantation (LT).

*Methods: All recipients undergoing LT at Mayo Clinic Florida (MCF) with donor livers with moderate macrosteatosis (30-60%) from 2000-2017 were identified (N=96). Routine protocol liver biopsies were performed 1 week and 6 months following LT. All liver donor and protocol biopsies were read by an experienced liver pathologist at MCF.

*Results: Of the 96 moderate macrosteatosis LTs, 70 recipients had post-LT protocol liver biopsies available and therefore comprised the study cohort. Median donor allograft macrosteatosis at the time of transplant was 33% (IQR 30-40%) compared to 0% (IQR 0-2%) at 1 week (p<0.001) and 0% (IQR 0-0%) at 6 months (p<0.001) following LT. Biopsies at 1 week post-LT displayed pericentral necrosis in 57.1% of recipients and lipopeliosis in 34.3% of recipients. In the 6 month post-LT biopsies cholestasis was seen in 3 (4.3%) of recipients, while grade 2 fibrosis was seen in 6 recipients (8.6%). Graft survival at 5 years in the present cohort was 75.3%.

 border=

*Conclusions: Moderate Macrosteatosis (30-60%) in the donor allograft demonstrates complete reversal on liver biopsies performed as early as 7 days following LT and remains absent at 6 months following LT. Both pericentral necrosis and lipopeliosis are common features on day 7 biopsies. Longterm graft survival is excellent in recipients who are able to overcome the immediate perioperative risk of utilizing moderately steatotic donor livers.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Croome K, Livingston D, Taner C, Nakhleh R. Sequential Protocol Biopsies Post-Liver Transplant from Donors with Moderate Macrosteatosis: What Happens to the Fat? [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/sequential-protocol-biopsies-post-liver-transplant-from-donors-with-moderate-macrosteatosis-what-happens-to-the-fat/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences